Company attributes
Location
B2X
Founder
Pitchbook URL
Investors
Total Funding Amount (USD)
2,500,000
Latest Funding Round Date
May 18, 2009
Former CEO
Latest Funding Type
Other attributes
Company Operating Status
Active
Discontinued Date
2014
PlexPress is a company that creates gene expression analysis and transcript analysis using affinity capture to capture molecules from cell lysate. PlexPress produces and markets services within Finland and Europe.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.